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Purpose: Impairment of wound healing is a major issue in type-2 diabetes that often causes
chronic infections, eventually leading to limb and/or organ amputation. Connective tissue
growth factor (CTGF) is a signaling molecule with several roles in tissue repair and
regeneration including promoting cell adhesion, cell migration, cell proliferation and angio-
genesis. Incorporation of CTGF in a biodegradable core-shell fiber to facilitate its sustained
release is a novel approach to promote angiogenesis, cell migration and facilitate wound
healing. In this paper, we report the development of CTGF encapsulated electrospun dual
porous PLA-PVA core-shell fiber based membranes for diabetic wound healing applications.
Methods: The membranes were fabricated by a core-shell electrospinning technique. CTGF
was entrapped within the PVA core which was coated by a thin layer of PLA. The developed
membranes were characterized by techniques such as Scanning Electron Microscopy (SEM),
Fourier Transform Infrared Spectroscopy (FTIR) and X-Ray Diffraction (XRD) analysis. In
vitro cell culture studies using fibroblasts, keratinocytes and endothelial cells were performed
to understand the effect of CTGF loaded membranes on cell proliferation, cell viability and
cell migration. A chicken chorioallantoic membrane (CAM) assay was performed to deter-
mine the angiogenic potential of the membranes.
Results: Results showed that the developed membranes were highly porous in morphology
with secondary pore formation on the surface of individual fibers. In vitro cell culture studies
demonstrated that CTGF loaded core-shell membranes improved cell viability, cell prolifera-
tion and cell migration. A sustained release of CTGF from the core-shell fibers was observed
for an extended time period. Moreover, the CAM assay showed that core-shell membranes
incorporated with CTGF can enhance angiogenesis.
Conclusion: Owing to the excellent cell proliferation, migration and angiogenic potential of
CTGF loaded core-shell PLA-PVA fibrous membranes, they can be used as an excellent
wound dressing membrane for treating diabetic wounds and other chronic ulcers.
Keywords: diabetic wound, CTGF, electrospinning, PVA, PLA
Introduction
Diabetes mellitus is a devastating disease with more than 400 million people
affected globally.1 Chronic ulcers with deep tissue damage in patients with diabetes
leads to a high rate of amputation and mortality. Diabetic wounds typically show
delayed healing, persistent inflammation, abnormally high exudate production and
high bacterial load.2 Impaired diabetic wound healing is associated with multiple
factors including but not limited to abnormal fibroblast and keratinocyte prolifera-
tion, reduced cell migration and decreased angiogenesis.3 These complications
ultimately lead to impairment of vascularization, delayed wound contraction and
subsequent formation of non-healing diabetic wounds.
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During the past few decades, various biomolecules
such as vascular endothelial growth factor (VEGF),4 epi-
dermal growth factor (EGF),5 platelet derived growth fac-
tor (PDGF)6 and connective tissue growth factor (CTGF)7
have been tried as suitable treatment regimens for mana-
ging diabetic wounds.8 For instance, CTGF can play an
important role in promoting cell proliferation, cell migra-
tion and angiogenesis which will improve diabetic wound
healing.9–11 An earlier study demonstrated that recombi-
nant CTGF stimulates collagen and fibronectin synthesis
in cells,12 and CTGF also promotes the proliferation,
migration and differentiation of endothelial cells which
are essential for angiogenesis in the wound.13 However,
the successful clinical application of CTGF in diabetic
wounds is limited due to the lack of required bioactivity
in the highly oxidative wound environment which neces-
sitates controlled delivery to the wound.14
In order to minimize complications associated with
diabetic wounds, appropriate wound coverage matrices
with microbial barrier properties, exudate uptake capacity
and wound healing properties should be used.15–17 On the
other hand, a controlled release system is undoubtedly
necessary for the delivery of expensive and less stable
agents, such as growth factors. The application of biode-
gradable porous membranes loaded with CTGF to deliver
them in a tightly regulated manner could be a good
approach for promoting diabetic wound healing. In order
to ensure the successful encapsulation and controlled
delivery of the active agent inside the wound coverage
matrix, a rational design of the polymeric carrier is
required. Polymeric hydrogels such as poly(vinyl alcohol)
(PVA) can effectively encapsulate and deliver active
agents including growth factors.18 Due to its biodegrad-
ability, biocompatibility, low cost and ease of processing,
PVA has received wide acceptance for various biomedical
applications,19 particularly in wound dressing
applications.20,21 However, the ability of PVA to hold the
growth factor in the matrix and release it in a controlled
manner is limited due to the quick swelling of its amor-
phous matrix. A thin coating of a relatively hydrophobic
polymer over a PVA hydrogel could be a novel approach
to protect the loaded growth factor and facilitate its con-
trolled release. Poly(lactic acid) (PLA) can be a good
candidate for the coating because of its biodegradability,
biocompatibility and hydrophobicity.22,23 PLA is already
being used in biomedical applications such as tissue engi-
neering scaffolds, wound dressings, drug delivery systems
and sutures.24–26
Electrospinning is the most promising technique used to
produce highly porous fibrous membranes for various bio-
medical applications.27–29 This process has been successfully
exploited for the generation of continuous, ultra fine fibers
from polymers like poly(vinylidene fluoride-trifluoroethy-
lene) (P(VDF-TrFE)),30,31 polycaprolactone (PCL),32,33
polyvinyl alcohol (PVA),34 gelatin35 and have been used for
a diverse range of medical uses.36,37 Coaxial electrospinning
is a relatively recent approach to fabricate fibers from two
different polymers where one polymer forms the core and the
other forms the shell or sheath.38–40 In order to obtain PVA
fibers (loaded with CTGF) coated with PLA, coaxial electro-
spinning was used in this study.
In this work, we report the development of electrospun
membranes composed of core-shell fibers loaded with
CTGF for diabetic wound healing applications. The
major rationale of this work was to design core-shell
structured fibers in such a way that the loaded CTGF in
the PVA core component would be released in a sustained
manner for an extended time period through the pores of
the PLA shell. Using a core-shell structure composed of a
PVA core containing CTGF and a PLA shell that regulate
release is an effective way for the sustained delivery of
CTGF, providing a long-term effect and to prevent over-
doses. To our knowledge, fabrication of PVA-PLA core-
shell fibers loaded with CTGF and their application in
diabetic wound healing have not been reported yet.
Herein, we hypothesize that the controlled release of
CTGF from core-shell fibers could promote fibroblast,
keratinocyte and endothelial cell proliferation/migration
and angiogenesis which could result in the rapid healing
of diabetic wounds. Developed membranes were tested for
morphological, physicomechanical and biological proper-
ties. Results of this study demonstrated that the presence
of CTGF in the membranes can enhance cell proliferation,
cell migration and angiogenesis which may improve dia-
betic wound healing.
Materials And Methods
Materials
Polyvinyl alcohol (PVA, Mn 90 103-80 103Da),
CTGF, dichloromethane and 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) used in this work
were purchased from Sigma-Aldrich. Poly-L-lactic acid
(PLLA, Mn 125 103-120 103Da) was obtained from
Akina, US. Phosphate buffered saline (PBS), keratinocyte
serum free medium, penicillin- streptomycin solution and
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bovine pituitary extract (BPE) were obtained from Gibco.
Live/Dead assay kits, DAPI (4’,6-diamidino-2-phenylin-
dole) and phalloidin stains were obtained from Invitrogen.
Fabrication Of PLA-PVA-CTGF
Electrospun Membranes
For the preparation of the membranes, a specific quantity of
CTGF was accurately weighed to obtain an effective CTGF
content in a PVA matrix and was ultra-sonicated for 15 mins
to thoroughly disperse them in PBS. Details of the optimiza-
tion of the coaxial electrospinning process were given in an
earlier publication.41 The required amount of PVA pellets
were dissolved in hot deionized water. Then, the prepared
PVA solutions were mixed with a CTGF solution to get a 6%
w/v PVA solution containing 0.1% w/w of CTGF. For the
PLA shell, a 10% PLLA solution was made in a DCM/DMF
(1:9 ratio) mixed solvent system. The electrospinning set up
comprised of two syringe pumps (infusion) with 10 mL
syringes containing polymer solutions, a high voltage
power supply providing a 15 kV DC voltage and a stationary
collector. Syringes were connected to a coaxial needle in
such a way that the PVA or PVA-CTGF solution came out
through the inner tube and PLA came out thorough the outer
tube of the coaxial needle. The flow rate of PVA and PLA
solutions was 0.5 mL h−1 and 3 mL h−1, respectively. The tip
to collector distance was maintained as 10 cm throughout the
experiment.
Characterization Of The PLA-PVA-CTGF
Electrospun Membranes
SEM Analysis
The morphology of the developed membranes was exam-
ined using a scanning electron microscope (SEM). Gold
coated core-shell membranes were imaged using FEI,
Nova NanoSEM, 450 FE-SEM at 10 kV. The fiber dia-
meter was calculated from the SEM images by using
ImageJ software.
Thermal Analysis
The thermal analysis was conducted by using Differential
Scanning Calorimetry (DSC) on pure PLA, PVA and PLA-
PVA core-shell structures and PLA-PVA-CTGF core-shell
structures under nitrogen flow. The nanofiber mats were
weighed in the range between 6–8 mg and then placed in
the aluminum pans. Then, it was loaded in a Perkin Elmer
Pyris 7 DSC and provided with increasing temperature
from 24 °C to 300 °C at a heating rate of 10 °C/min.
After a 1 min hold at 300 °C, pans containing samples
were cooled to 24 °C. After a hold of 1 min, samples were
again heated to 300 °C.
Fourier-Transform Infrared Spectroscopy (FTIR)
FTIR analysis was used to determine the specific chemical
composition of pure PLA, PVA and PLA-PVA core-shell
structures and PLA-PVA-CTGF core-shell structures. The
FTIR measurements were conducted using a PerkinElmer
(USA), Spectrum 400 FTIR instrument.
Mechanical Properties Of The PLA-PVA-
CTGF Membranes
To determine the tensile properties of PLA-PVA and PLA-
PVA-CTGF membranes, uniaxial tensile tests were per-
formed using a Tinus Olsen H50 KT Universal Testing
Machine (UTM) as per the standard procedure (ASTM D
882). Rectangular shaped membranes with 6×1 cm2
dimensions were used for the measurements. The experi-
ments were conducted by keeping a 3 cm gauge length.
The machine operated at a speed of 1 mm/min and apply-
ing a 500 N mechanical loading on the samples.
Swelling Studies
In order to avoid excess exudates produced by the wounds,
wound healing patches should have an optimal exudate
uptake capacity. For that reason, swelling studies were
performed on PLA-PVA and PLA-PVA-CTGF mem-
branes. The membranes were cut into a size of 2 cm in
length and 2–3 cm in width. The weight was measured
before and after immersing in PBS at different time frames
(0.5 to 144 h). The following Equation (1) was used to
determine the water uptake capacity of the samples:
Percentage of Swelling ¼
Wet weight Dry weightð Þ=Dry weight½  x 100 (1)
In Vitro CTGF Release
In vitro release studies were performed according to an
earlier report with slight modifications.42 Briefly, electro-
spun membranes weighing about 50 mg were placed in 12-
well plates filled with 3 mL DMEM medium and kept in
an incubator set to 37°C temperature. At predetermined
time points, 400 µl of the release medium was retrieved
from each well and replaced by 0.4 µl of fresh release
medium. The collected release medium was used for pro-
tein determination. The concentration of growth factors in
the supernatant was determined using a Pierce BCA pro-
tein estimation kit (Thermo Scientific) microplate method.
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In Vitro Cell Culture Studies
Viability Staining For Cytotoxicity Analysis
3T3 fibroblasts (ATCC CRL-1658, Passage-48), HaCat
keratinocytes (Passage-54) and EA.hy926 endothelial
cells (ATCC CRL-2922, Passage-27) were seeded on
pre-sterilized and pre-wetted scaffolds. The membranes
were cut into a 1 x 1 cm size and cells were seeded at a
final concentration of 2 × 104 cells/sample and cultured in
24-well plates. Both 3T3 fibroblasts and HaCat keratino-
cytes were maintained in DMEM (Gibco, Ireland) pro-
vided with 10% fetal bovine serum and a penicillin/
streptomycin solution (Gibco, US origin). EA.hy926
endothelial cells were maintained in endothelial cell med-
ium (Gibco, Ireland). All the cell seeded membranes were
incubated in an incubator with a 5% CO2 supply for 24 h,
3 days and 7 days. The LIVE/DEAD Cell Imaging Kit
(488/570) was used for the assay according to the protocol
described by the manufacturer (Molecular Probes,
Invitrogen, USA). After the incubation period, the cells
were washed with DPBS and then the prepared reagent
(100 µl) was added to each well. After 30 min of incuba-
tion at 38°C, the fluorescence images were taken using an
Olympus, FV300 microscope.
Cell Viability Assay
The effect of PLA-PVA and PLA-PVA-CTGF membranes
on mouse NIH 3T3 fibroblast, human HaCat keratinocyte
and human EA.hy926 endothelial cell proliferation were
assessed using MTT cell viability assays. The membranes
were cut into a 1 x 1 cm size and cells were seeded at a final
concentration of 2 × 104 cells/sample and cultured in 24-well
plates. The cell density was 2 x 104 cells/well in a 24 well
plate and cultured under appropriate conditions as described
in the previous section. All the cell seeded membranes were
incubated in an incubator with a 5% CO2 supply for 24 h, 3
days and 7 days, and MTT assays were performed according
to the manufacturer’s protocol (Molecular Probes, Invtrogen,
USA). Absorbance was recorded at 570 nm using an Infinite
F200 PRO (Tecan, Switzerland) microplate reader. All
experiments were repeated for a minimum of three times.
To calculate the effect of the scaffolds on cell viability,
Equation (2) was used:
Cell proliferation %ð Þ¼ OD of sample=OD of controlð Þ
X100 (2)
In Vitro Wound Healing Assay
An in vitro wound healing assay was performed by a wound-
healing scratch assay as described in.43 In brief, 3T3, HaCat
or EA.hy926 cells were seeded in a 12 well plate at a density
of 5 × 104 cells/well. When the cells reached confluency, a
scratch was made with the help of a 100 µL pipette tip. In
each well, pre-sterilized scaffolds (1x1 cm) were added. The
images were taken initially at the time of placing the mem-
branes and after 24 h with an Olympus inverted fluorescent
microscope (Olympus, UK). The wound contraction was
measured from the images using ImageJ software and the
scratch contraction (%) was determined using Equation (3):
Scratch contraction %ð Þ¼ Wd0Wdt =Wd0100 (3)
Where Wd° and Wdt are the gap between scratch edges
before and after time “t” of incubation with the samples,
respectively.
Angiogenic Properties Of The Developed
Core-Shell Membranes Using The CAM
Assay
For the CAM assay, fertilized chicken (Gallus domesticus)
eggs were purchased from Arab Qatari Poultry Production
Co. The eggs were incubated until day 4 at 37 °C from the
day of fertilization in a humidified egg incubator (The
Sportsman, Brookfield). After the incubation, the eggs were
taken out and cleaned with 70% ethanol. A circular window
was made from the broad edge of the egg with the help of a
scissor. A 1 cm2 PLA-PVA and PLA-PVA-CTGF electro-
spun membrane was placed on the exposed surface of CAM.
The exposed window was covered with transparent adhesive
tape. Then, it was again placed in a humidified 40% incubator
at 37 °C. After 24 h, the vascular development on the CAM
was observed with a stereo microscope and the number of
branching points and diameter of vessels were quantified
using Angioquant software.
Statistical Analysis
Unless specified, all the experimental procedures were carried
out in triplicate and the results were reported in terms ofmeans
and standard deviation. Statistical significance between differ-
ent groups were analyzed by a Student’s t-test using Minitab
statistical software from the means of each group (* P < 0.05
was considered as statistically significant).
Results
Characterization Of PLA-PVA-CTGF
Scaffolds
SEManalysis was performed to determine themorphological
features of PLA-PVA and PLA-PVA-CTGFmembranes. The
Augustine et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
International Journal of Nanomedicine 2019:148576
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
an
om
ed
ici
ne
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
17
6.
20
2.
13
0.
13
4 
on
 2
5-
Ju
l-2
02
0
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
obtained PLA-PVA and PLA-PVA-CTGF membranes were
highly porous and composed of randomly oriented fibers
with apparently the same individual fiber diameters
(Figure 1A and B). Neither of the membranes showed
beads or irregularities in/on the fibers. However, the surface
of the individual fibers was highly porous in nature. The
average fiber diameters were calculated from the SEM
micrographs (data not shown). The average individual fiber
diameter of neat PLA-PVA membranes was 2.6 ± 1.4 µm.
We did not observe a considerable difference between the
fiber morphology and diameters of the PLA-PVA and PLA-
PVA-CTGF membranes.
The XRD patterns of the PLA, PVA, PLA-PVA and
PLA-PVA-CTGF membranes are shown in Figure 1C. The
PLA samples exhibited an intense diffraction peak at 2θ of
16.8° indicating the presence of (110/200) planes and the
other less prominent peak observed at 19.1° corresponding
to the (010) plane.44 In addition, a minor peak at 14.5
corresponding to the (010) plane was also observed.45 The
XRD profile of the PVA showed an intense peak with a
maxima at 2θ 19.7° and a shoulder peak at 2θ 22° were
present.46 The PLA-PVA core-shell membranes showed
prominent peaks of PLA. Apart from the diffraction pat-
terns of PLA, one major peak of PVA which was centered
around 19.7 was also observed in the core-shell mem-
branes (marked by arrows in Figure 1C). We did not
observe a remarkable difference in the XRD patterns of
PLA-PVA and PLA-PVA-CTGF membranes.
FTIR analysis in attenuated total reflectance (ATR)
mode was used to examine the surface chemistry of
PLA, PVA, PLA-PVA and PLA-PVA-CTGF fibers
(Figure 1D). PVA fibers showed the characteristic peaks
of hydroxyl groups at 3200–3600 cm−1, however, which
were mostly not observed in the core-shell fibers. The
presence of hydroxyl peaks observed in certain samples
of the PLA-PVA and PLA-PVA-CTGF core-shell fibers
might be due to the presence of PVA or the PVA-CTGF
core component exposed to the outside of the PLA fibers
through the pores present on the surface. This indicated
that PVA was not exposed on the surface of the core-shell
fibers due to the presence of a PLA shell on the surface of
the fibers. This indicated the successful formation of the
core-shell fibers.
Figure 1E and F show the DSC heating and cooling
thermograms of the developed membranes. The melting
peak of PVA, which is about 220 °C according to the DSC
curve, was shifted to a low temperature in the heating
curves of the PLA-PVA core-shell fibers due to the
restriction of PVA chain mobility by PLA chains.
Further, the increased interaction that might exist between
the polymer chains of PLA and PVA impedes the crystal-
lization of both PLA and PVA, which can also be apparent
from the less intense crystallization peaks in the cooling
curves. Meanwhile, the crystallization of PVA in the core-
shell fibers was further retarded due to the presence of
CTGF. However, there was no significant effect on the
melting transition of the PLA-PVA core-shell fibers due
to the CTGF loading.
Tensile Properties Of The Membranes
Figure 2A–D shows the representative tensile stress–strain
curves and corresponding tensile properties of the devel-
oped membranes. From the stress-strain curves, it was
apparent that PLA exhibits a typical stress–strain behavior
with a linearly elastic region at low strain, followed by the
plastic deformation before breaking. Fracture strain and
yield stress of pure PLA were 80% and 2.8 MPa, respec-
tively. PVA membranes demonstrated an elongation at
break and ultimate tensile stress of 38.5 ± 8.8% and 1.9
± 0.6 MPa, respectively. However, PLA nanofibers
showed a high tensile strength and tensile modulus when
compared with PVA or PLA-PVA membranes, which
could be attributed to the difference in molecular organi-
zation within the polymer itself. The tensile moduli values
of PVA was 43.48 ± 7.31, whereas the stress at break was
2.05 ± 0.37 MPa. These results are in good agreement with
earlier studies.47
Both PLA-PVA and PLA-PVA-CTGF membranes
showed 73.08 ± 9.12 and 70.14 ± 11.23% maximum
elongation, respectively. Core-shell PLA-PVA and PLA-
PVA-CTGF membranes showed an ultimate tensile stress
of 2.62 ± 1.22 MPa and 3.12 ± 2.18 MPa, respectively.
Relatively similar tensile properties were observed for
core-shell PLA-PVA membranes with and without CTGF
indicating that the addition of a small quantity of CTGF
did not affect the elastic properties of the membranes.
Young’s moduli were apparently the same for all the
studied samples except bare PLA.
Exudate Uptake Capacity And CTGF
Release
Swelling of PLA-PVA-CTGF membranes were examined
to understand their exudate uptake capacity. Water uptake
capacity of PLA, PVA, PLA-PVA and PLA-PVA-CTGF
membranes are shown in Figure 3A. The neat PLA
Dovepress Augustine et al
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membrane showed low water uptake throughout the study
period which was about 25–30%. Neat PVA membranes
showed an initial sudden swelling. It reached up to the
peak of 275 ± 38% within 10 h of the study, then declined
slowly. This might be due to the dissolution of PVA fibers
in water. In the case of PLA-PVA-CTGF, a gradual
Figure 1 Results of morphological and physical characterization of the developed core-shell fiber-based membranes. Schematic representation of the fabrication process of
the core-shell membranes (A). SEM image of coaxial PLA-PVA-CTGF membranes showing the morphology (B). XRD patterns (C), FTIR spectra (D), DSC heating
thermogram (E) and DSC cooling thermogram (F) of fabricated membranes.
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increase in the water uptake was observed within 0–1 h of
the study which further improved gradually and reached a
peak uptake ranging from 74 to 95% at about 72 h of the
study. As evident for the obtained data, both PLA-PVA
and PLA-PVA-CTGF core-shell fibers were able to absorb
a good amount of water while being stable in water.
The combination of transient and prolonged release in
the early stages and later stages of wound healing, respec-
tively, is normally desirable for tissue regeneration. The
release profile of CTGF from core-shell fibers is shown in
Figure 3B. The concentration of CTGF, measured for 15
days, clearly indicates that the release was in a sustained
manner. The initial release (for the first 24h) was
comparatively higher compared to longer time points.
However, the release of CTGF was retained even after
15 days of the experiment.
CTGF Loaded Membranes Showed
Higher Fibroblast, Keratinocyte And
Endothelial Cell Viability
Live-Dead Staining
For the successful application of the developed mem-
branes as a wound dressing, native cells such as fibro-
blasts, keratinocytes and endothelial cells should present
sufficient cell viability. The observed live and dead cells
Figure 2 Mechanical testing results of the developed membranes. Stress-strain curve (A), Elongation at break (B), Ultimate tensile stress (C) and Young’s modulus (D) of
PLA, PVA, PLA-PVA and PLA-PVA-CTGF membranes. P-values were calculated using Student’s t-test where (*) indicates a significant difference from other group of
comparison (p ≤ 0.05).
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on the PLA-PVA and PLA-PVA-CTGF membranes are
given in Figure 4A. Fibroblast cells on the PLA-PVA
membranes showed a slightly smaller number of live
(green) cells as the green fluorescence was less in this
case. In contrast, fibroblast cells cultured on the CTGF
loaded membranes showed several green colored cells
compared to the controls and membranes without CTGF.
There was no considerable difference in dead fibroblast
cells (red colored) between the different treatment groups.
Almost all of the HaCat keratinocyte cells cultured with
the membranes were viable irrespective of their composi-
tion. In contrast, EA.hy926 endothelial cells showed a
considerable difference between the different sample treat-
ment groups. A higher number of live cells were observed
on those cells treated with PLA-PVA-CTGF membranes
compared to the neat PLA-PVA membranes. However, we
did not observe considerable variation in relative ratios of
live and dead cells, which indicated the non-toxicity of all
the tested membranes. The adhesion and proliferation of
fibroblasts, keratinocytes and endothelial cells on the fibers
are given in Figure S1.
Cell Viability By MTT Assay
To determine cell viability and growth of mammalian cells
on the developed membranes, 3T3 fibroblasts, HaCat ker-
atinocytes and EA.hy926 endothelial cells were seeded on
the membranes and MTT assays were performed. The
obtained results are given in Figure 4B. During the 7
days of the study period, PLA-PVA membranes were
cytocompatible, and possessed a comparable viability
with the control. PLA-PVA-CTGF membranes showed
greater cell viability compared to the bare PLA-PVA mem-
branes and control especially in the case of 3T3 fibroblasts
and HaCat keratinocytes. About a 113.5±4.5% viability
was observed on PLA-PVA-CTGF at 24h, which was
significantly different from the PLA-PVA treated cells.
On day-3 and day-7 after treatment, PLA-PVA-CTGF
treated fibroblasts showed a 115.7±5.4% and 117.4 ±
2.3% viability compared to the control, respectively.
From this, it was clear that there was no considerable
variation in cell viability with treatment time. However,
EA.hy926 endothelial cells cultured on the different mem-
branes did not show intergroup differences in viability up
to 3 days of cell culture. However, on the 7th day of
treatment, a significant difference in cell viability was
observed for PLA-PVA and PLA-PVA-CTGF membranes
compared to the earlier treatment periods. Moreover, the
viability of endothelial cells cultured on PLA-PVA-CTGF
membranes was higher on the 7th day of treatment com-
pared to the PLA-PVA membranes and controls. Overall,
these findings indicated that the developed membranes
loaded with CTGF are cytocompatible and are able to
support fibroblast, keratinocyte and endothelial cell growth
in vitro.
In Vitro Wound Healing
The migration of 3T3 fibroblasts, HaCat keratinocytes and
EA.hy926 endothelial cells in the presence of the CTGF
Figure 3 Water uptake capacity (A) and cumulative release (B) of PLA-PVA-CTGF membranes.
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loaded membranes was assessed using an in vitro cell migra-
tion assay (Figure 5). Wounds generated on controls and
PLA-PVA membrane-treated 3T3 cells showed a wound
contraction of 32.51 ± 6.44% and 36.08 ± 4.67%,
Figure 4 Results of in vitro cell culture studies on the developed membranes. Live/Dead assay results showing the viability of 3T3 fibroblasts, HaCat keratinocytes and EA.
hy926 endothelial cells which were cultured with the PLA-PVA and PLA-PVA-CTGF membranes (A). Scale bars = 200 µm. Viability of 3T3, HaCat and EA.hy926 cells upon
culturing with the scaffolds (B). P-values were calculated using Student’s t-test where (*) indicates a significant difference from the other group of comparison (p ≤ 0.05).
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respectively (Figure 5A, D). There was no significant differ-
ence between the control and PLA-PVA groups. However,
the PLA-PVA-CTGF membrane treated 3T3 cells showed a
54.34 ± 6.8% wound contraction. In the case of HaCat cells,
the scratch closure was generally slow where a 8.62 ± 2.34%
and 10.73±2.04% contraction was only observed on the
control and PLA-PVA treated cells (Figure 5B, 5D).
However, the PLA-PVA-CTGF treated membrane groups
showed a 45.54 ± 6.68% in vitro wound closure which was
significantly different from controls and neat PLA-PVA trea-
ted cells. Therefore, the presence of bare membranes did not
impair the normal in vitro migration rate of 3T3 and HaCat
cells. We also examined the potential of the developed mem-
branes to promote endothelial cell migration using an in vitro
wound contraction assay. The contraction of a scratch with
the PLA-PVAmembrane was about 45.47±1.50%, while, the
closure of the scratch with the control was 43.45±4.58%
(Figure 5C and D). There was no significant difference
found in the healing of the scratch with the PLA-PVA mem-
branes and the controls. However, the CTGF loaded PLA-
PVA membranes showed a significant difference in wound
contraction which was about 58.64%±3.46%. Figure 5E
and F show the variation in the morphology of keratinocytes
upon incubation with PLA-PVA and PLA-PVA-CTGFmem-
branes. Unlike the cells grown in the presence of PLA-PVA
membranes, those grown in the presence of PLA-PVA-
CTGF membranes had an elongated cell morphology.
PLA-PVA-CTGF Membranes Showed
Higher Angiogenesis In A CAM Model
The effect of the developed membranes on angiogenesis
was evaluated by an in ovo chicken chorioallantoic mem-
brane (CAM) assay. Figure 6A shows the appearance of a
network of blood vessels growing around the PLA and
PLA-PVA membranes. As a control, PBS showed no
effect on angiogenesis. It is evident from the results that
the PLA-PVA-CTGF membranes have a higher ability to
promote angiogenesis compared to the other samples.
Similarly, CTGF loaded membranes exhibited more angio-
genesis by showing an increased number of blood vessels
around the PLA-PVA-CTGF membranes (Figure 6B). In
addition, significantly higher blood vessel diameters were
Figure 5 Results showing the effect of PLA-PVA and PLA-PVA-CTGF scaffolds on in vitro wound healing using 3T3 fibroblasts (A), HaCat keratinocytes (B) and EA.hy926
endothelial cells (C). Wound contraction (%) after treatment with the developed membranes (D). Morphological changes in HaCat cells which were incubated with PLA-
PVA and PLA-PVA-CTGF membranes (E). Schematic representation of phenotypic changes of keratinocyte cells upon incubation with PLA-PVA-CTGF scaffolds (F). P-values
were calculated using a Student’s t-test where (*) indicates a significant difference from the control (p ≤ 0.05). The images were taken at 100X magnification.
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also observed for the PLA-PVA-CTGF membranes com-
pared to the control (Figure 6C).
Discussion
Electrospun membranes have been widely investigated for
wound dressing and tissue engineering applications with
several promising outcomes.48 Major advantages of electro-
spun membranes that make them suitable for wound cover-
age applications are good elasticity, a high surface area to
volume ratio, high air permeability and the extracellular
matrix mimicking morphology. Here in this research, we
developed electrospun core-shell membranes based on PVA
and PLAwhere the growth factor, CTGF, was loaded in the
PVA core.We performed initial optimization studies to deter-
mine the optimum electrospinning parameters, such as
applied voltage, flow rate, solvent polarity, solvent volatility,
solution concentration, temperature and humidity. It was
observed from the SEM images that the obtained PLA-PVA
membranes were composed of submicron fibers with a
highly porous architecture (about 80% porosity based on
the alcohol diffusion method) and individual fibers with
almost similar diameters. Such a high porosity of the fibers
facilitates appropriate oxygen andwater permeability49 while
preventing the entry of microbes to the wounds.50 Secondary
pore formation was also observed on the individual fibers.
We have observed that humidity played a critical role in the
formation of secondary pores on fibers. At a relatively high
humidity in the spinning environment, breath-moisture based
pore formation can happen due to the condensation of dro-
plets from the air and subsequent difference in the rate of
evaporation of the solvent from the surface.51 It has already
been reported that such secondary pore formation could be
highly advantageous for providing appropriate
nanotopographical52,53 and textural cues for cell adhesion
Figure 6 Effect of PLA-PVA-CTGF on angiogenesis in vivo was evaluated by in ovo model of chicken chorioallantoic membrane (CAM) assay (A). Fold increase in blood
vessel junctions (B) and fold increase in blood vessel diameter (C) after 24 hrs of treatment with samples. # indicates the core-shell membranes. P-values were calculated
using one-way ANOVA where (*) indicates a significant difference from the other group of comparison (p ≤ 0.05). The images were taken at 10X magnification.
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and proliferation on the fibers.54 As a novel aspect of this
study, pores present in the PLA shell facilitate the sustained
release of CTGF. Electrospinning has been employed as a
versatile technique to fabricate delivery vehicles for various
drugs and biomolecules.55 Biomolecules (such as growth
factors) that are susceptible for denaturation in the presence
of organic solvents which are used in conventional electro-
spinning can be loaded in fibers produced by coaxial electro-
spinning. During coaxial electrospinning, hydrophilic
proteins can be preserved in the core water phase of fibers
and their bioactivity could be retained to a large extent. The
presence of a porous shell of PLA over the CTGF loaded
PVA core could provide a sustained release of CTGF for an
extended period. Information on the formation of the core-
shell structure of PLA-PVA membranes was obtained from
XRD analysis. Core-shell membranes have shown the pre-
sence of prominent peaks of PLAwith less intense peaks for
PVA. The absence of FTIR peaks corresponding to the
hydroxyl groups of PVA in the core-shell fiber membranes
indicate the successful formation of core-shell structures.
The crystallization of PVA in the core-shell fibers was
slightly affected in the PLA-PVA-CTGF membranes due to
the presence of CTGF.
Sufficient elasticity and mechanical strength are
required for a wound coverage matrix to prevent discom-
fort and failure during muscular movements. Bare PVA
showed relatively less tensile strength since they were
uncrosslinked.56 The presence of a PLA shell over PVA
improved the tensile strength of the PLA-PVA fibrous
membranes. This might be due to the fact that more
mechanically strong PLA coatings over PVA fibers pre-
vented the failure of relatively week PVA chains. The
results of tensile testing revealed that the addition of
CTGF had no significant influence on the tensile properties
of PLA-PVA membranes. Owing to its adequate flexibility,
elasticity and tensile strength, PLA-PVA-CTGF mem-
branes can mechanically fit the defective areas and can
avoid motion associated failure.
Effective wound management aims to produce a bal-
ance, ie a moist environment to promote healing but not so
wet as to cause maceration and excoriation.57 It is often
difficult to select a dressing that is effective in healing,
removes excess exudate and causes no trauma while also
providing barrier functions until the wound is healed com-
pletely. In general, an optimum wound coverage material
should provide a moist wound environment in the healing
wound, offer protection from infections and support tissue
regeneration.58 They also should be able to absorb excess
wound exudates produced by the chroninc wounds.59 Thus,
we evaluated the ability of PLA-PVA-CTGF membranes to
absorb water to estimate its exudate management capacity.
The neat PLA membrane showed low water uptake due to
hydrophobic methyl groups in its structure. The limited
water uptake shown by bare PLA could be initiated in the
amorphous regions of PLA, since it is less organized and
more accessible to water molecules.60 Corroborating evi-
dence from other studies on PVA-clay nanocomposites for
wound dressing applications showed a relatively similar
trend as observed in the current research.61 PLA-PVA-
CTGF membranes had an appropriate capacity to hold
large amounts of exudate which make them suitable candi-
dates for even highly exudative wounds.
Furthermore, the gradual swelling behavior of PLA-
PVA-CTGF membranes will be beneficial in continu-
ously exuding wounds over a long duration.62 In addi-
tion, developed membranes will create a moist
environment in the wound bed and support moist
wound healing.63 Moreover, surfaces with moderate
hydrophilicity support the adsorption of proteins
released from the cells and facilitate cell adhesion,
while hydrophobic surfaces show poor cell
attachment.64 Since they are highly porous, they will
be permeable to water and provide aeration.65
However, the application of a PVA dressing with
excess water content alone in the wound can lead to
wound maceration.66 Thus, PLA-PVA-CTGF dressings
improve wound healing by providing a moist environ-
ment and absorbs excess wound exudate to prevent
leakage. In order to obtain desirable bioactivity, loaded
CTGF should be released in a controlled manner for
prolonged time periods. The swelling PVA core might
have resulted in the slow release of CTGF through the
nanopores of a PLA shell in a sustained fashion. The
initial burst release of CTGF from the PVA core could
be associated with the fast dissolution of PVA from the
pores which are directy exposed to the release medium.
Such an initial higher release of protein from core-shell
fibers was reported in earlier studies also.41 A subse-
quent slow release of CTGF form the PVA core can
play a significant role in effective cell proliferation,
angiogenesis and wound healing throughout the course
of healing.
The viability and proliferation of cells such as fibro-
blasts, keratinocytes and endothelial cells within wound
coverage matrices are important and have been estab-
lished by several earlier studies.67 CTGF plays several
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key roles that will activate and protect fibroblasts from
cell death.68 Earlier reports suggest that the application
of CTGF induces the expression of several genes includ-
ing those coding MMP and support fibroblast survival
and wound contraction.69 The observed higher viability
of fibroblast cells cultured with PLA-PVA-CTGF mem-
branes could be ascribed to this protective effect of
CTGF. Similarly, CTGF containing PLA-PVA mem-
branes enhanced the viability of HaCat cells. However,
the variation in the viability of endothelial cells was
minimal between different membranes; such a cell spe-
cific differential effect of CTGF has been reported in
earlier studies.70,71 For instance, CTGF protected
chicken embryo fibroblasts from apoptosis72 whereas it
induced apoptosis in human breast cancer cells.73 This
cell specific difference in the activity of CTGF might be
the reason for the observed difference in cell viability
observed here. Interestingly, PLA-PVA-CTGF core-shell
membranes showed a higher viability in the studied cells
even at the 7th day of treatment. The prolonged effect of
enhanced cell proliferation on the CTGF loaded core-
shell membranes could be due to the slow and sustained
release of CTGF through the pores of the fibers. We also
investigated the effect CTGF loaded membranes on the
migration of important cells associated with wound
healing such as fibroblasts, keratinocytes and endothelial
cells. The migration of all the three types of cells and
the contraction of the in vitro wounds were higher when
CTGF loaded core-shell scaffolds were used. CTGF has
been reported for its ability to promote the growth and
migration of several types of mammalian cells such as
vascular smooth muscle cells (VSMC),70 human mesan-
gial cells71 and endothelial cells.9 Fibroblasts and
endothelial cells showed a marginal improvement in
migration upon treatment with CTGF loaded mem-
branes. However, keratinocytes showed a very pro-
nounced effect in cell migration and wound contraction
due to the treatment of CTGF loaded core-shell mem-
branes. This considerable difference in the in vitro
wound contraction behavior of keratinocytes might be
due to the higher cell to cell adhesion and their less
potency of migration.72 In order to promote cell migra-
tion in keratinocytes, tight cell-cell adhesion of kerati-
nocytes should be disrupted with appropriate cues;73
such signals (mostly growth factors and chemokines)
can induce epithelial-mesenchymal transition (EMT) of
keratinocytes which facilitate their migration and prolif-
eration. Changes in the morphology of keratinocytes
treated with PLA-PVA-CTGF membranes indicated an
EMT. Since re-epithelialization of wounds including
chronic diabetic wounds depends upon the migration
of keratinocytes from the cut margins of the wound,
developed membranes containing CTGF with excellent
cell migratory potential can be a good candidate for
diabetic wound healing applications.
Inadequate angiogenesis plays an important role in the
formation of non-healing diabetic wounds.74 Due to the impor-
tance of promoting angiogenesis in diabetic wounds, we stu-
died the angiogenic properties of the developed core-shell
membranes. A superior angiogeneic response was observed
on chicken chorioallantoic membranes treated with PLA-
PVA-CTGF membranes. Our results are in line with earlier
reports regarding the angiogenic potential of CTGF.75,76
Higher endothelial cell migration, proliferation and survival
are required for mitigating the impaired angiogenesis in dia-
betic wounds. PLA-PVA-CTGF induced modulation in
endothelial cell viability and migration might have played a
significant role in angiogenesis in chicken chorioallantoic
membrane. We observed higher proliferation and migration
of endothelial cells when cultured with CTGF containing
PLA-PVA membranes. Earlier studies support our findings
regarding the observed higher cell proliferation.76 The present
study further confirms the bioactivity of CTGF released from
PVA core as evident from the increased blood vessel number
and diameter based on the CAM model.
Overall, the obtained results demonstrate that the CTGF
loaded core-shell fibers can have a significant positive impact
on the viability and migration of multiple cells that are
relevant in diabetic wound healing and facilitate subsequent
wound contraction. Since the effective dose and duration of
growth factor gradients are important factors that facilitate
angiogenesis and wound healing, a slow release of CTGF
might have significantly contributed to the overall perfor-
mance of the developed membranes.7 Future studies should
focus on the effect of PLA-PVA-CTGF on cell proliferation,
angiogenesis, and wound closure rate in vivo using small
animal models. Detailed investigations are also required to
establish important parameters such as in vivo PLA-PVA
degradation, in vivo CTGF release kinetics, and pharmaco-
kinetics to further exploit the clinical potential of this bioac-
tive wound dressing.
Conclusions
In this work, electrospun PLA-PVA core-shell membranes
loaded with CTGF were developed and thoroughly charac-
terized for morphological, physio-mechanical and biological
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performance. SEM analysis provided the morphological
characteristics of the developed membranes. FTIR and
XRD analyses confirmed the formation of PLA-PVA core-
shell fibers. Core-shell membranes possessed adequate elas-
ticity, tensile strength, and tensile modulus to perform as an
appropriate wound dressing. Fibroblasts, keratinocytes and
endothelial cells were able to grow well on the CTGF loaded
membranes. Results of the in vitro scratch assay shows that
the membranes containing CTGF promoted cell migration
and supported fast in vitro wound closure. CTGF loaded
core-shell membranes have shown higher angiogenesis com-
pared to the neat PLA-PVA membranes and controls.
Overall, results indicated that CTGF loaded PLA-PVA
core-shell membranes can be used for diabetic wound heal-
ing applications. However, detailed in vivo biocompatibility,
hemocompatibility and wound healing studies need to be
undertaken before considering the clinical application of
the developed membranes.
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